Similar results were obtained in classical transgenic AD models with global overexpression of mutant proteins, in which a decrease in EAAT1 and EAAT2 levels was observed in hippocampi [181,182], along with reduced glutamate re-uptake activity [183] and altered glutamatergic neurotransmission [181]. Here, SLC1A3 is linked to Alzheimer disease.